News

A recent discovery from the Centenary Institute has been recognised as the 200th scientific breakthrough funded by cancer charity Tour de Cure since it began supporting research in 2007.

Professor Geoff McCaughan, senior researcher at the Centenary Institute’s Centre for Cancer Innovations, has shared his expert insights on ABC radio, discussing the growing global burden of liver cancer.

The Centenary Institute and Cure The Future Foundation have announced a new philanthropic partnership to accelerate research into life-changing treatments for rare genetic diseases and cancers.

A promising new COVID-19 vaccine candidate developed by researchers at the Centenary Institute and the University of Sydney has shown strong potential to protect against both current and emerging coronavirus variants. By targeting features shared by a range of coronaviruses, the vaccine is designed to offer broader and longer-lasting protection as the virus continues to evolve.

Scientists from the Centenary Institute and the University of Sydney have made a landmark discovery that could lead to safer and more effective gene therapies for a range of serious genetic disorders including Duchenne muscular dystrophy, Pompe disease and haemophilia.

Two researchers from the Centenary Institute have secured competitive Pipeline Accelerator Grants from Therapeutic Innovation Australia (TIA), supporting the development of promising medical innovations.

A research team led by Professor Jennifer Gamble from the Centenary Institute’s Centre for Healthy Ageing has been awarded a prestigious Catalyst Partnership Grant from the Heart Foundation.

Professor Mark Gorrell from the Centenary Institute’s Centre for Cancer Innovations has been awarded a Springer Nature Editorial Contribution Award celebrating his outstanding editorial work for the highly respected journal Scientific Reports. The award recognises editorial board members who have made a notable contribution to the journal’s peer-review and publishing processes. Professor Gorrell has served ...

Serena Li, a research assistant at the Centenary Institute, has recently been appointed as the Chair of the newly established ReST (Research Assistants, Support and Technicians) Association.

The Centenary Institute has hosted the 2025 Annual Research Symposium of the ‘Centre of Research Excellence in Tuberculosis Elimination (TB-CRE)’.

Researchers from the Centenary Institute have uncovered a reason why some people with haemophilia A develop resistance to their critical treatment, paving the way for the development of more effective therapies.

Researchers from the Centenary Institute, in collaboration with the University of Sydney, have developed a powerful new tool to evolve proteins directly within mammalian cells, offering a more effective way to design medical treatments tailored to the human body.